Showing 1 to 3 of 3 rows
See Report | Preferred Variant Title | Classification | Condition | Published Date | Version | Criteria Specification | Gene |
|---|---|---|---|---|---|---|---|
| View | NM_006767.4(LZTR1):c.742G>A (p.Gly248Arg) | Likely Pathogenic | RASopathy | 2024-09-30 | 1.2 | ClinGen RASopathy Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for LZTR1 Version 1.1.0 | LZTR1 |
| View | NM_006767.4(LZTR1):c.742G>A (p.Gly248Arg) | Likely Pathogenic | RASopathy | 2024-09-25 | 1.1 | ClinGen RASopathy Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for LZTR1 Version 1.1.0 | LZTR1 |
| View | NM_006767.4(LZTR1):c.742G>A (p.Gly248Arg) | Likely Pathogenic | RASopathy | 2024-09-25 | 1.0 | ClinGen RASopathy Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for LZTR1 Version 1.1.0 | LZTR1 |
Showing 1 to 3 of 3 rows